Entity Common Stock, Shares Outstanding of Enveric Biosciences, Inc. from 01 Aug 2011 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enveric Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 12 Nov 2025.
  • Enveric Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 596,978, a 94% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Enveric Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 596,978 -9,347,942 -94% 12 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 3,246,284 -5,673,636 -64% 13 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 2,471,656 -4,822,349 -66% 27 Mar 2025 10-K 28 Mar 2025 2024 FY
Q3 2024 9,944,920 +7,623,605 +328% 12 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 8,919,920 +6,772,014 +315% 09 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 7,294,005 +5,215,734 +251% 21 Mar 2024 10-K 26 Mar 2024 2023 FY
Q3 2023 2,321,315 +243,044 +12% 09 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,147,906 +573,142 +36% 09 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 2,078,271 -50,506,849 -96% 30 Mar 2023 10-K/A 09 Jun 2023 2022 FY
Q3 2022 2,078,271 -29,305,361 -93% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 1,574,764 -19,857,651 -93% 11 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 52,585,120 +33,134,613 +170% 30 Mar 2022 10-K 31 Mar 2022 2021 FY
Q3 2021 31,383,632 +23,892,088 +319% 09 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 21,432,415 +15,695,414 +274% 13 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 19,450,507 +16,203,802 +499% 29 Mar 2021 10-K 01 Apr 2021 2020 FY
Q3 2020 7,491,544 -55,329,245 -88% 13 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 5,737,001 -46,680,687 -89% 11 Aug 2020 10-K/A 12 Aug 2020 2019 FY
Q1 2020 3,246,705 -43,781,728 -93% 22 Mar 2020 10-K 25 Mar 2020 2019 FY
Q3 2019 62,820,789 +23,213,220 +59% 06 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 52,417,688 +29,544,241 +129% 09 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 47,028,433 +28,237,435 +150% 22 Mar 2019 10-K 26 Mar 2019 2018 FY
Q3 2018 39,607,569 +23,751,320 +150% 08 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 22,873,447 +8,223,035 +56% 08 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 18,790,998 +4,211,581 +29% 29 Mar 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 15,856,249 +1,970,277 +14% 30 Oct 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 14,650,412 +1,164,940 +8.6% 10 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 14,579,417 +2,705,056 +23% 20 Mar 2017 10-K/A 04 Apr 2017 2016 FY
Q3 2016 13,885,972 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 13,485,472 12 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 11,874,361 -3,535,638 -23% 15 Mar 2016 10-KT 15 Mar 2016 2015 T3
Q4 2015 11,639,066 16 Nov 2015 10-Q 23 Nov 2015 2016 Q2
Q1 2015 15,409,999 0 0% 20 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 15,409,999 +3,267,999 +27% 10 Nov 2014 10-Q 18 Aug 2015 2015 Q1
Q2 2014 15,409,999 +3,267,999 +27% 20 Jul 2014 10-Q 13 Nov 2014 2014 Q3
Q1 2014 15,409,999 +3,267,999 +27% 01 May 2014 10-Q/A 08 May 2014 2014 Q1
Q3 2013 12,142,000 0 0% 30 Sep 2013 10-Q 06 Nov 2013 2013 Q3
Q2 2013 12,142,000 0 0% 31 Jul 2013 10-Q 01 Aug 2013 2013 Q2
Q1 2013 12,142,000 0 0% 28 Feb 2013 10-K 28 Feb 2013 2012 FY
Q3 2012 12,142,000 0 0% 09 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 12,142,000 -52,858,000 -81% 31 Jul 2012 10-Q 01 Aug 2012 2012 Q2
Q1 2012 12,142,000 03 Mar 2012 10-K 07 Mar 2012 2011 FY
Q3 2011 12,142,000 31 Oct 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 65,000,000 01 Aug 2011 10-Q 02 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.